Related Experiment Video
Updated: Jun 20, 2026
Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
Published on: March 6, 2014
Haemorrhage detection in brain metastases of lung cancer patients using magnetic resonance imaging
Abstract:
Magnetic resonance susceptibility-weighted imaging (SWI) is a new, highly-sensitive technique used to detect haemorrhage. This study evaluated the ability of magnetic resonance imaging (MRI) to detect haemorrhage in 45 lung cancer patients with brain metastases and compared the results with T2*weighted imaging (T2*WI) and contrast-enhanced T1-weighted imaging (CE-T1WI). Eighty-nine haemorrhagic brain metastases were identified in 31 patients using SWI, 68 were identified in 23 patients using T2*WI and 46 were identified in 14 patients using CE-T1WI. Most micro-bleeds could only be identified by SWI. It was concluded that haemorrhage is a frequent occurrence in brain metastases originating from lung cancer and that haemorrhage can be detected using SWI in a majority of brain metastases patients.
Insights
Magnetic resonance susceptibility-weighted imaging (SWI) offers superior detection of brain haemorrhages in lung cancer patients with metastases. SWI identified more micro-bleeds than T2*weighted imaging (T2*WI) and contrast-enhanced T1-weighted imaging (CE-T1WI).
Area of Science:
- Neurology
- Oncology
- Radiology
Background:
- Brain metastases are a common complication of lung cancer.
- Detecting micro-haemorrhages in brain metastases is crucial for accurate diagnosis and treatment planning.
- Conventional MRI techniques have limitations in identifying small haemorrhagic foci.
Purpose of the Study:
- To evaluate the efficacy of magnetic resonance susceptibility-weighted imaging (SWI) in detecting haemorrhage in lung cancer patients with brain metastases.
- To compare the sensitivity of SWI with T2*weighted imaging (T2*WI) and contrast-enhanced T1-weighted imaging (CE-T1WI) for haemorrhage detection.
Main Methods:
- A study was conducted on 45 lung cancer patients diagnosed with brain metastases.
- Magnetic resonance imaging (MRI) was performed using SWI, T2*WI, and CE-T1WI sequences.
- The number of identified haemorrhagic brain metastases was compared across the different imaging modalities.
Main Results:
- SWI identified 89 haemorrhagic brain metastases in 31 patients.
- T2*WI detected 68 haemorrhages in 23 patients, while CE-T1WI identified 46 in 14 patients.
- SWI demonstrated superior sensitivity, detecting most micro-bleeds that were missed by T2*WI and CE-T1WI.
Conclusions:
- Haemorrhage is a frequent finding in brain metastases originating from lung cancer.
- SWI is a highly sensitive technique for detecting haemorrhage in brain metastases.
- SWI significantly improves the detection rate of haemorrhagic brain metastases compared to T2*WI and CE-T1WI.
